These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 7983603)

  • 41. The absorption characteristics of six sustained-release theophylline preparations.
    Sommers DK; van Wyk M; Meyer EC; Snyman JR; Moncrieff J
    S Afr Med J; 1992 Jan; 81(1):20-2. PubMed ID: 1729729
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Posture and circadian variations in serum theophylline concentrations].
    Kishida M; Hukushima K; Iikura Y
    Arerugi; 1990 Oct; 39(10):1422-6. PubMed ID: 2260930
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Nocturnal asthma: effect of a once per evening dose of sustained release theophylline.
    Neuenkirchen H; Wilkens JH; Oellerich M; Sybrecht GW
    Eur J Respir Dis; 1985 Mar; 66(3):196-204. PubMed ID: 3884358
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Therapeutic advantage of unequal dosing of theophylline in patients with nocturnal asthma.
    Dorow P; Steinijans VW
    Chronobiol Int; 1987; 4(3):349-57. PubMed ID: 3315265
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Administration-time-dependency of the pharmacokinetic behavior and therapeutic effect of a once-a-day theophylline in asthmatic children.
    Smolensky MH; Scott PH; Harrist RB; Hiatt PH; Wong TK; Baenziger JC; Klank BJ; Marbella A; Meltzer A
    Chronobiol Int; 1987; 4(3):435-47. PubMed ID: 3315272
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Efficacy of sustained release theophylline given at three different evening intake times in addition to a baseline medication.
    Siebert B; Kunkel G; Borner K; Staudinger HW; Steinijans VW
    Eur Respir J; 1990 Feb; 3(2):176-81. PubMed ID: 2178965
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Review of the North American experience with evening administration of Uniphyl tablets, a once-daily theophylline preparation, in the treatment of nocturnal asthma.
    Arkinstall WW
    Am J Med; 1988 Jul; 85(1B):60-3. PubMed ID: 3400688
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Chronopharmacokinetics of theophylline administered as a controlled-release tablet.
    Thielemann AM; Manquez N; Pinilla E; Gai MN; Romero P; Arancibia A; Chavez H
    Int J Clin Pharmacol Ther; 1996 Mar; 34(3):130-3. PubMed ID: 8705090
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Temporal variations in trough serum theophylline concentrations at steady state.
    Lesko LJ; Brousseau D; Canada AT; Eastwood G
    J Pharm Sci; 1980 Mar; 69(3):358-9. PubMed ID: 7381723
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Relationship between rate and extent of absorption of oral theophylline from Uniphyl brand of slow-release theophylline and resulting serum concentrations during multiple dosing.
    Milavetz G; Vaughan LM; Weinberger MM; Harris JB; Mullenix TA
    J Allergy Clin Immunol; 1987 Nov; 80(5):723-9. PubMed ID: 3680816
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Impact of ciprofloxacin on theophylline clearance and steady-state concentrations in serum.
    Schwartz J; Jauregui L; Lettieri J; Bachmann K
    Antimicrob Agents Chemother; 1988 Jan; 32(1):75-7. PubMed ID: 3348614
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Circadian variation in plasma theophylline concentrations during maintenance therapy with a sustained-release preparation in patients with obstructive airways disease.
    Taylor DR; Duffin D; Kinney CD; McDevitt DG
    Br J Clin Pharmacol; 1984 Jul; 18(1):27-30. PubMed ID: 6743488
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Pharmacokinetics of a theophylline sustained-release formulation after single and twice daily dosage].
    Fuchs WS; von Nieciecki A; Pabst G; Müller M; Dilger C; Gay S; Laicher A; Stanislaus F
    Arzneimittelforschung; 1998 May; 48(5A):589-92. PubMed ID: 9676350
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The effect of low-dose cimetidine (200 mg twice daily) on the pharmacokinetics of theophylline.
    Nix DE; Di Cicco RA; Miller AK; Boyle DA; Boike SC; Zariffa N; Jorkasky DK; Schentag JJ
    J Clin Pharmacol; 1999 Aug; 39(8):855-65. PubMed ID: 10434239
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Absorption characteristics of once-a-day slow-release theophylline preparation in children with asthma.
    Pedersen S; Steffensen G
    J Pediatr; 1987 Jun; 110(6):953-9. PubMed ID: 3585612
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Kinetics of absorption of a new once-a-day formulation of theophylline in the presence and absence of food.
    Harrison LI; Mitra AK; Kehe CR; Klinger NM; Wick KA; McCarville SE; Cooper KM; Chang SF; Roddy PJ; Berge SM
    J Pharm Sci; 1993 Jun; 82(6):644-8. PubMed ID: 8331541
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A "once a day administration" sustained-release theophylline formulation: disposition and pharmacokinetics.
    Soubeyrand J; Comet F; Gillet A; Georges D; Brazier JL
    Eur J Clin Pharmacol; 1984; 27(3):325-8. PubMed ID: 6510460
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Bioavailability of theophylline from a sustained-release aminophylline formulation (Euphyllin retard tablets)--plasma levels after single and multiple oral doses.
    Schuppan D; Molz KH; Staib AH; Rietbrock N
    Int J Clin Pharmacol Ther Toxicol; 1981 May; 19(5):223-7. PubMed ID: 7251238
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Chronopharmacokinetics of theophylline in the cat.
    Dye JA; McKiernan BC; Neff-Davis CA; Koritz GD
    J Vet Pharmacol Ther; 1990 Sep; 13(3):278-86. PubMed ID: 2231868
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pharmacokinetics of an ultralong sustained-release theophylline formulation when given twice daily in elderly patients with chronic obstructive pulmonary disease: monitoring implications.
    Armijo JA; Sánchez BM; Peralta FG; González-Ruiz M; Cuadrado A; Verdejo A; Cos MA; Arjona R
    Biopharm Drug Dispos; 2003 May; 24(4):165-71. PubMed ID: 12698500
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.